May 13, 2008 ā€“ Echoserve launched an online portal designed to facilitate the research, purchase and sale of diagnostic ultrasound equipment, providing unbiased third-party information along with research tools to assist consumers with critical equipment decisions.

The site aggregates product data from a variety of sources and then arranges this information to ensure accuracy and thoroughness, aiming to allow purchasers to make educated decisions.

Edwards Lifesciences Corp. has rolled out a next-generation transfemoral delivery system for the Edwards SAPIEN transcatheter heart valve designed for transcatheter aortic valve replacement procedures.

TomTec Imaging Systems recently announced that its new CardioArena, the network and imaging solution for cardiology, will be released in 2008.

The CardioArena platform is a solution for 2D, 3D and 4D imaging data, and serves as multimodality platform for all major medical imaging systems such as ultrasound, MRI and in the cath lab. For existing enterprise PACS and C-PACS environments, CardioArena is an add-on solution.

The FDA cleared CryoLifeā€™s CryoValve SG pulmonary human heart valve processed with the companyā€™s proprietary SynerGraft technology, providing a valve replacement option for children born with heart defects or for replacement surgery.

CryoLifeā€™s proprietary SynerGraft technology is designed to remove allogeneic donor cells and cellular remnants from the valve without compromising the integrity of the underlying collagen matrix.

The Promote RF CRT-D and Current RF ICD feature InvisiLink radiofrequency (RF) telemetry for reportedly secure, wireless communication between the implanted device and the programmer, have extended their reach with the new Durata lead.

The Edwards Lifesciences unveiled a new software upgrade that allows greater flexibility to trend and analyze the patient parameters using its FloTrac system at the 2008 American Association of Critical Nurses National Teaching Institute May 3-8 Chicago.

Siemens received FDA 510(k) clearance for Artis zeego, a robotic-assisted positioning capability for interventions in both radiology and cardiology, as well as the developing OR environment, designed to offer greater flexibility of movement and image acquisition.

Boston Scientific Corp. said the FDA approved three products in its Cardiac Rhythm Management business, including the CONFIENT implantable cardioverter defibrillator (ICD), the LIVIAN cardiac resynchronization therapy defibrillator (CRT-D) and an upgraded LATITUDE Patient Management System.

The CONFIENT ICD reportedly features an enhanced AV (atrial ventricular) Search Hysteresis designed to reduce unnecessary right ventricular pacing.

The FDA granted 510(k) clearance for the AIGISRX CRMD Anti-Bacterial Envelope by Tyrxpharma, a cardiac rhythm medical device intended to immobilize and reduce bacterial infection of a pacemaker or implantable cardioverter defibrillator (ICD) in order to create a stable environment when implanted in the body.

Medtronicā€™s Endeavor Zotarolimus-Eluting Coronary Stent System is engineered for the treatment of coronary artery disease. Endeavor uses the Driver bare metal cobalt alloy stent platform and the drug zotarolimus along with the proprietary, biocompatible drug delivery polymer.

Subscribe to
Ā© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now